GSK Dividend History & Description — GSK plc GSK is a biopharma company. Co. is engaged in making vaccines and specialty medicines to prevent and treat disease. Co.'s research and development focuses on the science of the immune system, human genetics and advanced technologies primarily in the following four therapeutic areas: infectious diseases, HIV, oncology and immunology/respiratory. Co.'s two reportable segments include: Commercial Operations and Total research and development.
Name:
GSK plc
Website:
www.gsk.com
Sector:
Drugs & Pharmaceuticals
Number of ETFs Holding GSK:
12 (see which ones )
Total Market Value Held by ETFs:
$208,808,267
Total Market Capitalization:
$124,832,000,000
% of Market Cap. Held by ETFs:
0.17%
Name: GSK plc
Website: www.gsk.com
Sector: Drugs & Pharmaceuticals
Number of ETFs Holding GSK: 12 (see which ones )
Total Market Value Held by ETFs: $208,808,267
Total Market Capitalization: $124,832,000,000
% of Market Cap. Held by ETFs: 0.17%
Quotes delayed 20 minutes
Hold 2.11 out of 4)
3rd percentile
GSK | GSK plc | Dividend History | Dividend Channel | www.DividendChannel.com
Copyright © 2010 - 2024, All Rights Reserved
Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use
and Privacy Policy . Video widget and dividend videos powered by Market News Video . Quote data delayed at least 20
minutes; data powered by Ticker Technologies , and Mergent . Contact Dividend Channel ; Meet Our Editorial Staff .
DividendChannel.com
Free GSK Email Alerts:
